67 related articles for article (PubMed ID: 12118347)
1. Free flap coverage of pyoderma gangrenosum leg ulcers.
Classen DA; Thomson C
J Cutan Med Surg; 2002; 6(4):327-31. PubMed ID: 12118347
[TBL] [Abstract][Full Text] [Related]
2. The role of split-thickness skin grafting in the treatment of vasculitic and pyoderma gangrenosum ulcers in a multidisciplinary wound centre.
Suoniemi L; Salmi T; Huhtala H; Kaartinen I; Kiiski J; Kimpimäki T
Int Wound J; 2024 Jun; 21(6):e14943. PubMed ID: 38899689
[TBL] [Abstract][Full Text] [Related]
3. Nonhealing Leg Ulcer as the Presentation of Sarcoidosis: A Case Report.
Shatnawi NJ; Al-Zoubi NA; Al-Bakkar LA; Gharaibeh LM; Hamouri S
Int J Low Extrem Wounds; 2023 Dec; 22(4):742-747. PubMed ID: 34374584
[TBL] [Abstract][Full Text] [Related]
4. Wound Debridement in Pyoderma Gangrenosum.
Taheri A; Mansoori P; Sharif M
Adv Skin Wound Care; 2024 Feb; 37(2):107-111. PubMed ID: 38241454
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable Temporizing Matrix for the Reconstruction of a Pyoderma Gangrenosum Wound.
Prasidha I; Barker A; Knight R; Haertsch P
Dermatol Surg; 2024 Jan; 50(1):112-114. PubMed ID: 37831970
[No Abstract] [Full Text] [Related]
6. Pyoderma gangrenosum successfully treated with split-thickness skin grafting in combination with negative pressure wound therapy: A case report.
Saito N; Sagara C; Terada A; Akasaka E; Nakano H; Nakajima K; Sawamura D
J Dermatol; 2024 May; 51(5):e156-e157. PubMed ID: 38009910
[No Abstract] [Full Text] [Related]
7. Necrotizing fasciitis versus pyoderma gangrenosum: securing the correct diagnosis! A case report and literature review.
Bisarya K; Azzopardi S; Lye G; Drew PJ
Eplasty; 2011; 11():e24. PubMed ID: 21625613
[TBL] [Abstract][Full Text] [Related]
8. Pyoderma gangrenosum-like ulcer in a patient with X-linked agammaglobulinemia: identification of Helicobacter bilis by mass spectrometry analysis.
Murray PR; Jain A; Uzel G; Ranken R; Ivy C; Blyn LB; Ecker DJ; Sampath R; Lee CC; Turner ML
Arch Dermatol; 2010 May; 146(5):523-6. PubMed ID: 20479300
[TBL] [Abstract][Full Text] [Related]
9. Postsurgical Pyoderma Gangrenosum After Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Case Report.
Varas-Rodríguez E; Cedeño F; Gonzalez-Diaz G; Vivas J; Salgueiro A; Dávila K; Nevarez Pomales O; Duyos O
JBJS Case Connect; 2023 Oct; 13(4):. PubMed ID: 38015935
[TBL] [Abstract][Full Text] [Related]
10. Postsurgical pyoderma gangrenosum and flap necrosis in a head and neck cancer patient following neck dissection.
Arebro J; Palmgren B
Clin Case Rep; 2020 Jul; 8(7):1121-1125. PubMed ID: 32695340
[TBL] [Abstract][Full Text] [Related]
11. Hypertrophic scar mimicking peristomal pyoderma gangrenosum.
Ito T; Yamamoto T
An Bras Dermatol; 2024; 99(2):290-292. PubMed ID: 38102049
[No Abstract] [Full Text] [Related]
12. Understanding multi-kinase inhibitor-associated cutaneous ulcers may provide molecular insights into the aetiology of pyoderma gangrenosum: A comment on Jeon et al.
Pham JP; Flora A; Frew JW
Australas J Dermatol; 2024 May; 65(3):e81-e84. PubMed ID: 38337172
[No Abstract] [Full Text] [Related]
13. Classic pyoderma gangrenosum.
Prete M; Racanelli V; Leone P; Favoino E; Perosa F
Clin Case Rep; 2024 Feb; 12(2):e8446. PubMed ID: 38389963
[TBL] [Abstract][Full Text] [Related]
14. Pyoderma Gangrenosum of the Genitalia, Anus, and Perineum: Two Case Reports and a Review of Published Cases.
Choe SI; Shettig A; Kody S; Vague M; Hoff A; Rios-Duarte JA; Ortega-Loayza AG
Sex Transm Dis; 2024 Apr; ():. PubMed ID: 38647256
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum following COVID-19 infection.
Syed K; Chaudhary H; Balu B
J Community Hosp Intern Med Perspect; 2021; 11(5):601-603. PubMed ID: 34567448
[No Abstract] [Full Text] [Related]
16. NETosis Is Induced by Complement Component 5a: Implications in the Pathogenesis of Pyoderma Gangrenosum.
Wang Z; Hornick N; Vague M; Yang D; Keller J; Kody S; Leachman S; Ortega-Loayza AG; Liu Y
J Invest Dermatol; 2024 Jan; 144(1):184-188.e2. PubMed ID: 37516310
[No Abstract] [Full Text] [Related]
17. Psychosocial impact of pyoderma gangrenosum: a patient perspective.
Crowder D; Herbert S; Haughton R
Br J Dermatol; 2023 Jul; 189(1):125-128. PubMed ID: 36916517
[No Abstract] [Full Text] [Related]
18. Analyzing global research trends and focal points of pyoderma gangrenosum from 1930 to 2023: visualization and bibliometric analysis.
Zyoud SH
J Transl Med; 2024 May; 22(1):508. PubMed ID: 38802936
[No Abstract] [Full Text] [Related]
19. Successful treatment of multiple site involvement pyoderma gangrenosum with baricitinib.
Wang Z; Li T; Gong L; Song Z; Piao Y
Int J Dermatol; 2024 May; ():. PubMed ID: 38727093
[No Abstract] [Full Text] [Related]
20. Inflammatory and vaso-occlusive ulcers: Part II - Management.
Hines A; Kody S; Shakshouk H; Fett N; Alavi A; Ortega-Loayza A
J Am Acad Dermatol; 2024 Mar; ():. PubMed ID: 38432460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
